Pronulife® GlucoCtrl

1 of 15 products in this brand
Pronulife® GlucoCtrl is a probiotic product designed to support blood glucose management. Its formulation includes key ingredients such as Lactobacillus salivarius, Bifidobacterium lactis, and Lactobacillus reuteri. This product is primarily targeted at the food and nutrition market, with a specific focus on applications related to nutrition and well-being, particularly in the category of nutraceuticals and supplements.

Ingredient Name: Probiotic Blend

Functions: Probiotic

Benefit Claims (Health): Blood Glucose Management

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar

Enhanced TDS

Identification & Functionality

Ingredient Name
Food Ingredients Functions
Pharma & Nutraceuticals Functions

Features & Benefits

Benefit Claims (Health)
Food Ingredients Features
Product Features
  • Better efficacy
  • Stronger immunity
  • Shorter recovery time
  • Function: Glucose Control
Product Background

Type 1 Diabetes

  • Type 1 diabetes, also known as "insulin-dependent diabetes," is an autoimmune disease resulting from damaged pancreatic β-cells, leading to insufficient insulin production.
  • It affects 5-10% of diabetes cases and usually develops in childhood or adolescence.
  • Unfortunately, it cannot be cured, requiring lifelong insulin injections for treatment, and it can have long-term effects on overall health and other organs.

Gut Microbiota and Glucose Metabolism

  • Imbalanced gut microbiota disrupts metabolism, affecting blood sugar regulation.
  • In autoimmune disease patients, Bacteroidota bacteria associated with metabolism and obesity increase, while Bacillota bacteria (formerly Firmicutes), which strengthen the gut barrier, decrease.
  • Reduced butyrate-producing bacteria in type 1 diabetes patients impact mucus synthesis and intestinal integrity, allowing microbial antigens to trigger autoimmune diseases.
  • Gut microbiota changes, dietary habits, and inflammatory fluctuations influence metabolism.
  • The gut microbiome modulates blood sugar metabolism through SCFAs produced by probiotics and incretins secreted by gut cells, vital in regulating glucose metabolism.

Applications & Uses

Use Level
1.0 x 10¹⁰ CFU
Application Information
  • R&D Center has selected powerful probiotic strains (Bifidobacterium animalis subsp. lactis CP-9, Lactobacillus johnsonii MH-68, and Lactobacillus salivarius AP-32) known for their effective blood sugar control in type 1 diabetes.
  • Studies have shown that Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 protect β-cells, stabilize blood sugar, and improve liver and kidney functions affected by diabetes.
  • Clinical research demonstrates that Pronulife® GlucoCtrl probiotics improve glycated hemoglobin levels, stabilize blood sugar, reduce inflammatory hormones, and enhance anti-inflammatory hormones.
  • NGS analysis reveals increased abundance of beneficial gut bacteria.


  • Lactobacillus johnsonii MH-68
  • Lactobacillus salivarius AP-32
  • Bifidobacterium animalis subsp. lactis CP-9
  • Lactobacillus reuteri GL-104